Genexa, an Atlanta-based company founded by two dads, Max Spielberg and David Johnson, has made a significant presence in the consumer pharmaceutical space by producing the first clean OTC medicine products in the industry. Using Genexa’s patented preservation system, the company’s products deliver the same active ingredients as other OTC medicine, but for the first time ever they are without common allergens like lactose and gluten, artificial dyes, parabens, polyethylene glycol, talc and many other, potentially harmful and unnecessary inactive ingredients.
According to Genexa cofounder Spielberg, “We did not accept the feedback we got from countless manufacturers who told us that artificial binders and fillers were necessary in OTC medicines to keep them shelf stable, so we set out to bring together the leading medical experts and business minds in the industry to create a better solution.” Johnson adds, “Through the innovative products we are creating and the breakthroughs we’ve made with OTC medicines, we hope to inspire others in the industry to further our mission to clean up the medicine aisle and offer cleaner, healthier solutions for everyone.”
Last month Genexa closed a record-breaking $60 million Series A funding round, which further substantiates that a shift is under way toward clean medicine not unlike the pervasive consumer trends that have been affecting the food and beverage industry, beauty and personal care, and all other major segments over the last ten years. Some of the best-regarded venture capital firms and a large roster of A-List celebrity investors participated in the latest round of funding, and are committing to cleaning up the industry, educating consumers and making clean medicine more readily available. Today, Genexa’s products can be found at 45,000 retailers, including Walmart, Target, CVS, Walgreens and Rite Aid.